CXCL5 and neoplasm: In colorectal cancer, CXCL5 mediates epithelial-mesenchymal transition (EMT) by activating the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin signaling pathway, which promotes tumor cell migration and invasion and liver metastases (26).